STING1 and metabolic dysfunction-associated steatotic liver disease: STING expression was found to be significantly upregulated in the liver of patients with NAFL [22], while STING expression in macrophages/Kupffer cells (KCs) could promote the progression of NAFLD via the mediation of hepatic inflammation and fibrosis [23,24], suggesting that STING activation promotes NAFLD progression.